Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
31 studies found for:    " November 14, 2012":" December 14, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" November 14, 2012":" December 14, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed An Evaluation of a Rapid Test for HIV
Condition: HIV Seropositivity
Intervention: Device: Rapid testing for HIV
2 Completed Testing a Secondary Prevention Intervention for HIV-Positive Black Young Men Who Have Sex With Men
Conditions: HIV;   AIDS
Interventions: Behavioral: MOVE Intervention;   Behavioral: H4L Comparison Intervention
3 Completed Project ACCEPT: Engaging Newly Diagnosed HIV+ Youth in Care
Condition: HIV Positive Youth That Are Newly Engaged in Care.
Interventions: Behavioral: Project ACCEPT;   Behavioral: HEALTH
4 Completed Boston Alcohol Research Collaboration on HIV/AIDS (ARCH) Cohort
Conditions: HIV Infection;   Alcohol Use;   Bone Disease;   Substance-Related Disorders
5 Completed Veterans Living With HIV/AIDS: A Pilot Study Examining Risk Factors Associated With Self-Directed Violence
Conditions: Human Immunodeficiency Virus Infection(HIV)/Acquired Immunodeficiency Syndrome (AIDS);   Self-Directed Violence
6 Recruiting Neurocognitive Effects of Opiate Agonist Treatment
Conditions: Opioid-Related Disorders;   HIV;   HIV Infections
Interventions: Drug: Buprenorphine;   Drug: Methadone
7 Withdrawn A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects
Condition: Human Immunodeficiency Virus Infection
Interventions: Drug: amdoxovir 300 mg bid;   Drug: amdoxovir 500 mg bid
8 Terminated A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects.
Condition: Human Immunodeficiency Virus Infection
Interventions: Drug: amdoxovir 300 mg bid;   Drug: amdoxovir 500 mg bid;   Drug: tenofovir DF 300 mg qd
9 Terminated Safety and Efficacy of (α1Proteinase Inhibitor, α1PI) in HIV Disease
Condition: HIV Disease
Intervention: Biological: α1 Proteinase Inhibitor
10 Completed Vitamin D Absorption in HIV Infected Young Adults Being Treated With Tenofovir Containing cART
Condition: HIV Infection
Interventions: Dietary Supplement: Vitamin D3 50,000 IU;   Dietary Supplement: Vitamin D3 placebo
11 Recruiting Safety Study of a Dual Anti-HIV Gene Transfer Construct to Treat HIV-1 Infection
Condition: Human Immunodeficiency Virus
Interventions: Drug: Busulfan;   Biological: Cal-1 modified HSPC;   Biological: Cal-1 modified CD4+ T lymphocytes
12 Unknown  Efficacy of Antifolates Against Malaria in HIV-infected Pregnant Women and the Emergence of Induced Resistance in Plasmodium Falciparum
Conditions: Malaria in Pregnancy;   HIV Infection
Interventions: Drug: cotrimoxazole daily prophylaxis;   Drug: sulphadoxine-pyrimethamine
13 Recruiting Evaluating the Safety, Tolerance, and Pharmacokinetics of a Raltegravir-Containing Antiretroviral Therapy (ART) Regimen in Children Infected With HIV and TB
Conditions: HIV Infections;   Tuberculosis
Intervention: Drug: Raltegravir
14 Withdrawn The Feasibility of Using a General Health Screen to Increase HIV Testing in Community Pharmacies
Condition: HIV Infections
Interventions: Behavioral: HIV Test Offer;   Behavioral: General Health Screen Offer
15 Completed Interaction Between Etravirine or Darunavir/Ritonavir and Artemether / Lumefantrine
Condition: HIV
Interventions: Drug: Etravirine;   Drug: Darunavir/ritonavir;   Drug: artemether/lumefantrine
16 Completed A Post Marketing Survey Study to Evaluate the Safety and Effectiveness of Intelence
Condition: Acquired Immune Deficiency Syndrome
Intervention: Drug: No intervention
17 Active, not recruiting A Post Marketing Survey Study to Evaluate the Safety and Effectiveness of Prezista
Condition: Acquired Immune Deficiency Syndrome
Intervention: Drug: No intervention
18 Recruiting Does Rosuvastatin Delay Progression of Atherosclerosis in HIV
Conditions: HIV;   Cardiovascular Disease
Interventions: Drug: Rosuvastatin;   Other: Placebo
19 Recruiting Doxycycline for COPD in HIV-Infected Patients
Conditions: HIV;   Chronic Obstructive Pulmonary Disease (COPD);   Emphysema
Interventions: Drug: Doxycycline;   Drug: Placebo (sugar pill)
20 Completed
Has Results
Testing a Community-Friendly Risk Reduction Intervention for Injection Drug Users
Conditions: HIV;   Opioid Dependence
Interventions: Behavioral: Community-friendly Health Recovery Program;   Behavioral: Time-and-Attention-Matched Control Condition

   Previous Page Studies Shown (1-20) Next Page (21-31) Show next page of results    Last Page
Indicates status has not been verified in more than two years